OncoCyte
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $115 | $104 | $176 | $314 |
Gross Profit | 50 | 50 | -335 | -95 |
EBITDA | -13,122 | -4,196 | -8,779 | 4,077 |
EBIT | -13,462 | -4,522 | -9,114 | 3,763 |
Net Income | -13,493 | -4,530 | -9,129 | -15,992 |
Net Change In Cash | 115 | 104 | 176 | 314 |
Free Cash Flow | -5,336 | -6,169 | -3,854 | -4,826 |
Cash | 3,363 | 9,256 | 5,578 | 9,432 |
Basic Shares | 13,714 | 12,870 | 8,263 | 8,261 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $1,503 | $958 | $7,727 | $1,216 |
Gross Profit | 413 | -18 | 188 | -639 |
EBITDA | -23,123 | -13,315 | -48,457 | -30,540 |
EBIT | -24,803 | -18,535 | -52,662 | -30,934 |
Net Income | -27,781 | -73,440 | -64,097 | -29,932 |
Net Change In Cash | 1,503 | 958 | 7,727 | 1,216 |
Cost of Revenue | -14,102 | 28,462 | -14,929 | |
Free Cash Flow | -23,606 | -49,908 | -38,188 | -27,207 |
Cash | 9,432 | 19,993 | 35,605 | 7,143 |
Basic Shares | 7,651 | 5,540 | 4,446 | 3,273 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.98 |
2024-06-30 | -$0.36 |
2024-03-31 | -$2.12 |
2023-12-31 | -$2.07 |
